arrow
S

Suzanne L. Wolden

queen's university
H指数:75
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis

南亚区域合作联盟(SAARC)地区儿童癌症负担:一项基于人群的横断面GLOBOCAN 2022分析

2026-07-010
OAAI
Recommendations for radiation treatment in pediatric patients with metastatic rhabdomyosarcoma: Expert consensus from the International Soft Tissue SaRcoma ConsorTium (INSTRuCT)

国际软组织肉瘤联盟(INSTRuCT)关于转移性横纹肌肉瘤儿科患者放射治疗的专家共识建议

2026-05-060
PRE
A Prospective Trial Identifying Functional Neuroimaging Biomarkers of Impaired Neurocognition and Quality of Life After Proton Beam Radiotherapy (PBRT) for Treatment of Brain Tumors in Pediatric Patients

一项前瞻性试验,旨在识别儿童脑肿瘤患者接受质子束放射治疗(PBRT)后神经认知功能受损和生活质量的功能性神经影像生物标志物。

2025-11-010
OAAI
Local Control with Reduced-Dose Radiotherapy for High-Risk Neuroblastoma: Results from a Prospective Clinical Trial

高风险神经母细胞瘤的局部控制与减量放射治疗:前瞻性临床 trial 结果

2025-10-190
PRE
Impact of substructure radiation dose on health-related quality of life in children with brain tumors: a Pediatric Proton/Photon Consortium Registry (PPCR) study

脑肿瘤儿童中子/光子剂量对健康相关生活质量的影响:一项儿科质子/光子联盟登记研究(PPCR)

2025-09-090
OAAI
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR)

多层菊形团胚胎性肿瘤(ETMR)放射治疗后的结果:来自儿科质子/光子联盟登记处(PPCR)的结果

2025-05-130
PRE
Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children’s Oncology Group

放疗剂量递增未能改善中危横纹肌肉瘤的局部控制:儿童肿瘤组报告

2025-04-020
PRE
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
CANCER
IF5.1
2024-06-280
PRE
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study

基于风险的治疗对神经母细胞瘤幸存者晚期发病率和死亡率的影响: 来自儿童癌症幸存者研究的报告

2024-03-091
PRE
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
2022-11-1230
OAAI